These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8153269)

  • 1. Assessing prevention effectiveness using data to drive program decisions.
    Thacker SB; Koplan JP; Taylor WR; Hinman AR; Katz MF; Roper WL
    Public Health Rep; 1994; 109(2):187-94. PubMed ID: 8153269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative policy analysis and public health policy: a macro and micro view.
    Hinman AR
    Am J Prev Med; 1997; 13(1):6-11. PubMed ID: 9037336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness.
    Lebovic GS; Hollingsworth A; Feig SA
    Breast; 2010 Aug; 19(4):260-7. PubMed ID: 20399656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of public health demonstration programs: the effectiveness and cost-effectiveness of WISEWOMAN.
    Finkelstein EA; Wittenborn JS; Farris RP
    J Womens Health (Larchmt); 2004 Jun; 13(5):625-33. PubMed ID: 15257854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
    van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
    Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research evaluation and policy in dental public health.
    Lipton JA
    Curr Opin Dent; 1991 Jun; 1(3):329-36. PubMed ID: 1839360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Gardner JG; Bapat B; Kramer C
    Eval Program Plann; 2008 May; 31(2):136-44. PubMed ID: 18359084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation as a component in the evaluation of a prevention program].
    Rydlewska-Liszkowska I
    Med Pr; 2004; 55(6):469-75. PubMed ID: 15887515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for the Expanded Programme on Immunization.
    Cutts FT; Waldman RJ; Zoffman HM
    Bull World Health Organ; 1993; 71(5):633-9. PubMed ID: 8261567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention, policy, and paradox: what is the value of future health?
    Ganiats TG
    Am J Prev Med; 1997; 13(1):12-7. PubMed ID: 9037337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the benefits of increasing measles immunization rates.
    Zwanziger J; Szilagyi PG; Kaul P
    Health Serv Res; 2001 Oct; 36(5):885-909. PubMed ID: 11666109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and cost-effectiveness of colorectal cancer prevention and therapy.
    Schrag D; Weeks J
    Semin Oncol; 1999 Oct; 26(5):561-8. PubMed ID: 10528905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.